News & Updates

The risk of developing long COVID is high among women, hypertensives, and those with a higher number of initial symptoms, and these associations are independent of disease severity and clinical course, a study has found.

Patients diagnosed with COVID-19 could have an increased risk of certain conditions up to 120 days post-diagnosis, a finding which could help establish the definition of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), according to a study presented at CROI 2022.

A single-institution study does not recommend the prescription of systemic corticosteroids for the treatment of severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD) as this might result in an increased incidence of adverse effects and readmissions.

The use of empiric antibiotic therapy appears to prevent neither deterioration nor death among patients with COVID-19 pneumonia, as shown in a Singapore study.

Patients with type 1 diabetes mellitus (T1DM) may experience a temporary change in their blood glucose levels in the first week following COVID-19 vaccination, according to a small English study.

Individuals with poly(A)-specific ribonuclease (PARN) mutation are likely to have idiopathic pulmonary fibrosis (IPF), but other interstitial lung disease (ILD) subtypes may also occur, according to a study.

The progression of COVID-19 disease during pregnancy from asymptomatic or mild symptoms to moderate, severe, or critical symptoms is consistent regardless of trimester, according to a prospective study presented at SMFM 2022.